Actinium Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 7AY1?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	158,140	0.507%
Institutions	9,630,324	30.9%
General Public	21,407,427	68.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 28.91% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.32%	BlackRock, Inc.	1,972,041	€2.2m	1.73%	no data
5.18%	The Vanguard Group, Inc.	1,617,372	€1.8m	-0.47%	no data
2.47%	District 2 Capital LP	769,452	€840.2k	0%	12.33%
2.2%	Geode Capital Management, LLC	687,853	€751.1k	0.25%	no data
1.99%	State Street Global Advisors, Inc.	621,075	€678.2k	3.06%	no data
1.6%	Acadian Asset Management LLC	499,260	€545.2k	10%	no data
0.81%	Medical Strategy GmbH, Asset Management Arm	253,465	€276.8k	0%	0.02%
0.81%	Northern Trust Global Investments	251,930	€275.1k	4.92%	no data
0.76%	Bigger Capital, LLC	235,691	€257.4k	0%	1.79%
0.69%	Los Angeles Capital Management LLC	213,950	€233.6k	25%	no data
0.68%	Morgan Stanley, Investment Banking and Brokerage Investments	211,010	€230.4k	151%	no data
0.67%	SEI Investments Management Corporation	210,480	€229.8k	22.3%	no data
0.61%	Renaissance Technologies LLC	190,400	€207.9k	49.9%	no data
0.59%	Squarepoint OPS LLC	183,262	€200.1k	25.4%	no data
0.48%	Michael Bigger	150,170	€164.0k	0%	no data
0.39%	Deutsche Asset & Wealth Management	123,134	€134.5k	414%	no data
0.38%	Millennium Management LLC	117,454	€128.3k	-26.7%	no data
0.35%	JPMorgan Chase & Co, Brokerage and Securities Investments	110,002	€120.1k	17,200%	no data
0.32%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	99,346	€108.5k	0%	no data
0.3%	Goldman Sachs Group, Investment Banking and Securities Investments	94,959	€103.7k	104%	no data
0.29%	Creative Financial Designs Inc, Asset Management Arm	91,007	€99.4k	42.7%	0.01%
0.28%	UBS Asset Management AG	88,816	€97.0k	140%	no data
0.25%	Bank of America Corporation, Asset Management Arm	78,601	€85.8k	76.9%	no data
0.24%	Bridgeway Capital Management, LLC	75,700	€82.7k	-1.69%	no data
0.23%	Charles Schwab Investment Management, Inc.	72,093	€78.7k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/19 13:25
End of Day Share Price	2025/03/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Actinium Pharmaceuticals, Inc. is covered by 16 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
George Zavoico	B. Riley Securities, Inc.
Yuan Zhi	B. Riley Securities, Inc.
John Newman	Canaccord Genuity